USAN Watch: September 2013

The USANs for September, 2013 have recently been published. We actually missed September, due to switch over in service for the INNs, but now they're here.

USAN	Research Code	InChIKey (Parent)	Drug Class	Therapeutic class	Target
aducanumab	BIIB-037	n/a	monoclonal antibody	therapeutic	beta amyloid
aptorsen-sodium	OGX-427	n/a	oligonucleotide	therapeutic	HSP27
asfotase-alfa	ALXN-1215, ENB-0040	n/a	enzyme	therapeutic	n/a
batefenterol, batefenterol-succinate	GSK-961081A	URWYQGVSPQJGGB-DHUJRADRSA-N	synthetic small molecule	therapeutic	Muscarinic receptors, B2 receptor
bococizumab	RN-316, PF-04950615	n/a	monoclonal antibody	therapeutic	PC9
dactolisib, dactolisib-tosylate	NVP-BEZ235-NX	JOGKUKXHTYWRGZ-UHFFFAOYSA-N	synthetic small molecule	therapeutic	MTOR, PI3K
deldeprevir, deldeprevir-sodium	ACH-0142684, ACH-2684	UDMJANYPQWEDFT-ZAWFUYGJSA-N	synthetic small molecule	therapeutic	HCV NS3 PR
etiguanfacine	SSP-1871	NWKJFUNUXVXYGE-UHFFFAOYSA-N	synthetic small molecule	therapeutic
faldaprevir, faldaprevir-sodium	BI-201335		synthetic small molecule	therapeutic	HCV NS3 PR
fedratinib	SAR-302503; TG-101348	JOOXLOJCABQBSG-UHFFFAOYSA-N	synthetic small molecule	therapeutic	FLT3, JAK2
grazoprevir	n/a	n/a	synthetic small molecule	therapeutic
irinotecan-sucrosofate	MM-398, PEP-02	n/a	natural product derived small molecule	therapeutic	topo 1
luspatercept	ACE-536	n/a	protein	therapeutic	TGF-B family
mavoglurant	AFQ-056	ZFPZEYHRWGMJCV-ZHALLVOQSA-N	synthetic small molecule	therapeutic	mGluR5
otlertuzumab	TRU-016	n/a	monoclonal antibody	therapeutic	CD37
ralpancizumab	RN317, PF-05335810	n/a	monoclonal antibody	therapeutic	PC9
romyelocel-l	CLT-008	n/a	cellular therapy	therapeutic	n/a
roxadustat	FG-4592; ASP-1517	YOZBGTLTNGAVFU-UHFFFAOYSA-N	synthetic small molecule	therapeutic	prolyl hydoxylase
simtuzumab	AB-0024; GS-6624	n/a	monoclonal antibody	therapeutic	LOXL2
sucroferric-oxyhydroxide	PA-21	n/a	inorganic	sequestering agent	n/a
tecemotide	BLP-25	n/a	peptide vaccine	peptide vaccine	n/a